Health
Nanobodies inhibit SARS-CoV-2 infection, including emergent variants – Phys.org
Australian researchers have identified neutralizing nanobodies that block the SARS-CoV-2 virus from entering cells in preclinical models.
Australian researchers have identified neutralizing nanobodies that block the SARS-CoV-2 virus from entering cells in preclinical models.
The discovery paves the way for further investigations into nanobody-based treatments for COVID-19.
Published in PNAS, the research is part of a consortium-led effort, bringing together the expertise of Australian academic leaders in infectious diseases and antibody therapeutics at WEHI, the Doherty Institute and the Kirby Institute.
Using alpaca ‘nanobodies’…
-
Noosa News20 hours agoRocky waters ahead for Brisbane 2032’s Olympic rowing plan
-
General22 hours agoEV buses join Perth’s wider suburban network, ‘milestone’ for diesel phase-out
-
Noosa News10 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
Noosa News20 hours agoWoman loses arm in lion attack at Darling Downs Zoo in Queensland